Funding Report: The Life Science funding landscape in Sweden 2015-2019
Industrifonden has reviewed the funding flows into Swedish life science companies, focusing on Therapeutics, HealthTech, Diagnostics and Medtech, over the last five years (2015-2019). The report covers funding across the life cycle, from grants, to incubator and angel funding, on to venture capital (VC) and the stock markets; the amounts increase for each step. During this 5-year period, a handful of successful exits, some public, some private, generated funding flows back to investors of about 22 bnSEK. With 35 bnSEK recently invested – exciting times ahead!